AU2011257335A1 — Substituted 5-fluoro-1H-pyrazolopyridines and use thereof
Assigned to Adverio Pharma GmbH · Expires 2012-12-20 · 13y expired
What this patent protects
The present application relates to novel substituted 5-fluoro-lH-pyrazolopyridines, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prophylaxis of disorders, and to the use thereof for production of medicaments for treatment a…
USPTO Abstract
The present application relates to novel substituted 5-fluoro-lH-pyrazolopyridines, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prophylaxis of disorders, and to the use thereof for production of medicaments for treatment and/or prophylaxis of disorders, especially for treatment and/or prophylaxis of cardiovascular disorders.
Drugs covered by this patent
- Verquvo (VERICIGUAT) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.